Literature DB >> 20022060

In vitro, ex vivo and in vivo isotherms for renal cryotherapy.

Jennifer L Young1, Surendra B Kolla, Donald L Pick, Petros Sountoulides, Oskar G Kaufmann, Cervando G Ortiz-Vanderdys, Victor B Huynh, Adam G Kaplan, Lorena A Andrade, Kathryn E Osann, Michael K Louie, Elspeth M McDougall, Ralph V Clayman.   

Abstract

PURPOSE: Preoperative planning for renal cryotherapy is based on isotherms established in gel. We replicated gel isotherms and correlated them with ex vivo and in vivo isotherms in a porcine model.
MATERIALS AND METHODS: PERC-17 CryoProbes (1.7 mm) and IceRods (1.47 mm) underwent trials in gel, ex vivo and in vivo porcine kidneys. Temperatures were recorded at 13 predetermined locations with multipoint thermal sensors.
RESULTS: At the cryoprobe temperatures were not significantly different along the probe in any medium for either system (p = 0.0947 to 0.9609). However, away from the probe ex vivo and in vivo trials showed warmer temperatures toward the cryoprobe tip for each system (p = 0.0003 to 0.2141). Mean +/- SE temperature 5 mm distal to the cryoprobe tip in vivo was 19.2C +/- 16.1C for CryoProbes and 27.3C +/- 11.2C for IceRods. Temperatures were consistently colder with CryoProbes than with IceRods in gel (p <0.00005), ex vivo (p <0.00005) and in vivo (p = 0.0014). At almost all sites temperatures were significantly colder in gel and in ex vivo kidney than in in vivo kidney for CryoProbes (p = 0.0107 and 0.0008, respectively) and for IceRods (each p <0.00005).
CONCLUSIONS: Gel and ex vivo isotherms do not predict the in vivo pattern of freezing. Thus, they should not be used for preoperative planning. The cryoprobe should be passed 5 mm beyond the tumor border to achieve suitably cold temperatures. Multipoint thermal sensor probes are recommended to record actual temperature during renal cryotherapy. Copyright 2010 American Urological Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20022060     DOI: 10.1016/j.juro.2009.09.072

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

Review 1.  Targeted prostate biopsy and MR-guided therapy for prostate cancer.

Authors:  David A Woodrum; Akira Kawashima; Krzysztof R Gorny; Lance A Mynderse
Journal:  Abdom Radiol (NY)       Date:  2016-05

2.  Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection.

Authors:  Katayoun Samadi; Ronald S Arellano
Journal:  Diagn Interv Radiol       Date:  2018-11       Impact factor: 2.630

3.  Methods for characterizing convective cryoprobe heat transfer in ultrasound gel phantoms.

Authors:  Michael L Etheridge; Jeunghwan Choi; Satish Ramadhyani; John C Bischof
Journal:  J Biomech Eng       Date:  2013-02       Impact factor: 2.097

4.  Efficacy of percutaneous cryoablation of renal cell carcinoma in older patients with medical comorbidities: Outcome study in 70 patients.

Authors:  Erich K Lang; Kan Karl Zhang; Quan Nguyen; Leann Myers; Mahamed Allaf; Ivan Colon
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

5.  Factors Affecting Lethal Isotherms During Cryoablation Procedures.

Authors:  Andrew C Rau; Ryan Siskey; Jorge A Ochoa; Tracy Good
Journal:  Open Biomed Eng J       Date:  2016-06-29

6.  Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.

Authors:  Christiaan G Overduin; Sjoerd F M Jenniskens; J P Michiel Sedelaar; Joyce G R Bomers; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2017-04-13       Impact factor: 5.315

7.  The Impact of Placement Errors on the Tumor Coverage in MRI-Guided Focal Cryoablation of Prostate Cancer.

Authors:  Pedro Moreira; Kemal Tuncali; Clare M Tempany; Junichi Tokuda
Journal:  Acad Radiol       Date:  2020-08-27       Impact factor: 5.482

8.  Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors.

Authors:  Tim J van Oostenbrugge; Jan Heidkamp; Michael Moche; Phil Weir; Panchatcharam Mariappan; Ronan Flanigan; Mika Pollari; Stephen Payne; Marina Kolesnik; Sjoerd F M Jenniskens; Jurgen J Fütterer
Journal:  Cardiovasc Intervent Radiol       Date:  2020-09-15       Impact factor: 2.740

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.